MRAM CEO exercises options for 51,024 shares

EVERSPIN TECHNOLOGIES INC.

(High)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

EVERSPIN TECHNOLOGIES INC. President and CEO Sanjeev Aggarwal reported routine equity compensation activity. On May 20, 2026, he exercised employee stock options to acquire a total of 51,024 shares of common stock, consisting of 39,446 shares at $5.62 per share and 11,578 shares at $8.17 per share. Corresponding option positions for these amounts were reduced to zero, and a footnote states that the options were fully vested at the time of exercise. The filing shows only exercises and no open-market sales, indicating a shift from derivative awards into direct common stock ownership.

Insider Trade Summary

51,024 shares exercised/converted

Exercise 4 txns

Insider Aggarwal Sanjeev

Role President and CEO

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	11,578	$0.00	$0.00
Exercise	Employee Stock Option (Right to Buy)	39,446	$0.00	$0.00
Exercise	Common Stock	11,578	$8.17	$95K
Exercise	Common Stock	39,446	$5.62	$222K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 870,446 shares (Direct)

Footnotes (1)

F1. Fully vested.

Key Figures

Options exercised at $5.62: 39,446 shares Options exercised at $8.17: 11,578 shares Total options exercised: 51,024 shares +2 more

5 metrics

Options exercised at $5.62 39,446 shares Employee stock options exercised into common stock at $5.62 per share

Options exercised at $8.17 11,578 shares Employee stock options exercised into common stock at $8.17 per share

Total options exercised 51,024 shares Aggregate option exercises reported on May 20, 2026

Option expiration August 6, 2031 Original expiration date for the $5.62 strike option grant

Option expiration March 13, 2032 Original expiration date for the $8.17 strike option grant

Key Terms

Employee Stock Option (Right to Buy), Exercise or conversion of derivative security, fully vested

3 terms

Employee Stock Option (Right to Buy) financial

"Employee Stock Option (Right to Buy)"

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

fully vested financial

"Footnote states: Fully vested."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MRAM CEO Sanjeev Aggarwal report on this Form 4?

Sanjeev Aggarwal reported exercising employee stock options to acquire common shares. He converted option awards into 51,024 shares of EVERSPIN TECHNOLOGIES INC. common stock through two separate exercises, without any reported open-market sales in this filing.

How many MRAM shares did the CEO acquire through option exercises?

The CEO acquired 51,024 common shares through option exercises. This total comes from exercising options for 39,446 shares at one strike price and 11,578 shares at another strike price, as detailed in the Form 4 transaction records.

At what exercise prices were Sanjeev Aggarwal’s MRAM options converted to shares?

He exercised two tranches of options at different strike prices. One block of options converted into common stock at $5.62 per share and another block converted at $8.17 per share, according to the derivative transaction details.

Were the MRAM options exercised by the CEO already vested?

Yes, the options were fully vested at the time of exercise. A footnote in the Form 4 explicitly states “Fully vested,” indicating these employee stock options had already satisfied their vesting conditions before conversion into common stock.

Did the MRAM CEO sell any shares in this Form 4 filing?

No share sales are reported in this Form 4. All reported transactions involve the exercise of employee stock options and the acquisition of common stock, with no open-market sales, gifts, or tax-withholding dispositions disclosed in this filing.

What happened to the CEO’s MRAM employee stock options after these exercises?

The specific option positions tied to 39,446 and 11,578 underlying shares were reduced to zero. The derivative transaction lines show total derivative holdings for these options at 0.0000 following exercise, meaning those particular option grants are now fully exercised.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/21/2026 - 04:45 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aggarwal Sanjeev

(Last)

(First)

(Middle)

C/O EVERSPIN TECHNOLOGIES, INC.

5670 W. CHANDLER BLVD, STE 130

(Street)

CHANDLER

ARIZONA

85226

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EVERSPIN TECHNOLOGIES INC. [ MRAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/20/2026		M		11,578	A	$8.17	831,000	D
Common Stock	05/20/2026		M		39,446	A	$5.62	870,446	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$8.17	05/20/2026		M			11,578	⁽¹⁾	03/13/2032	Common Stock	11,578	$0	0	D
Employee Stock Option (Right to Buy)	$5.62	05/20/2026		M			39,446	⁽¹⁾	08/06/2031	Common Stock	39,446	$0	0	D

Explanation of Responses:

1. Fully vested.

Remarks:

	/s/ Cesare Suardi, Attorney-in-Fact for Sanjeev Aggarwal	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR